Diferenças entre homens e mulheres no risco de eventos adversos graves em pacientes que recebem imunoterapia, terapia-alvo ou quimioterapia em estudos clínicos oncológicos.

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials – Journal of Clinical Oncology

Comentários:

Women at higher risk of severe adverse events from cancer therapy – eCancer

Women Face Higher Risk for Severe AEs From Cancer Therapy – HealthDay

Comentário no Twitter

👀 Women had worse toxicity from #chemotherapy, #immunotherapy or #TargetedTherapy as compared to men in analysis of multiple @SWOG #clinicaltrials 👉 https://t.co/PjmnyJROb4 #leusm #CRCSM #LCSM @DrJoeUnger @DrDawnHershman pic.twitter.com/BJPZQoaI6g

— Journal of Clinical Oncology (@JCO_ASCO) February 23, 2022